NEW YORK, March 18, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) between October 10, 2023 and December 26, 2025, inclusive (the "Class Period"), of the important April 7, 2026...
Hence then, the article about ino deadline ino investors have opportunity to lead inovio pharmaceuticals inc securities fraud lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( INO Deadline: INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit )
Also on site :
- Ex-Belgian diplomat faces trial over Lumumba assassination
- What’s Inside This Year’s Oscar Goodie Bag?
- Sky Lands ‘Heated Rivalry’ Season 2, ‘Yaga’ Starring Hudson Williams & A24 Safdie Series ‘Superfakes’